A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer.

H Veelken; A Mackensen; M Lahn; G Köhler; D Becker; B Franke; U Brennscheidt; P Kulmburg; F M Rosenthal; H Keller

doi:10.1002/(sici)1097-0215(19970127)70:3<269::aid-ijc4>3.0.co;2-v

A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer.

Identifier:nobleid.org/w1/20260515/962ADA2B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/962ADA2B.svg?ark=w1%2F20260515%2F962ADA2B)](https://nobleid.org/work/w1/20260515/962ADA2B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer.

Identifier:nobleid.org/w1/20260515/962ADA2B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/962ADA2B.svg?ark=w1%2F20260515%2F962ADA2B)](https://nobleid.org/work/w1/20260515/962ADA2B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work